BA
Therapeutic Areas
Adicet Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Prulacabtagene leucel (prula-cel, ADI-001) | B-cell mediated Autoimmune Diseases (e.g., Systemic Lupus Erythematosus) | Phase 1 |
| Gamma Delta T Cell Platform | Solid Tumors | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Prulacabtagene leucel (prula-cel, ADI-001) | B-cell mediated Autoimmune Diseases (e.g., Systemic Lupus Erythematosus) | Phase 1 |
| Gamma Delta T Cell Platform | Solid Tumors | Preclinical |